Log in or Sign up for Free to view tailored content for your specialty!
Melanoma/Skin Cancer News
Melanoma staging system inaccurately reflects recurrence, mortality risk
Findings from a nationwide, population-based cohort study revealed that the current staging system used for melanoma does not represent accurate recurrence and mortality.
RNA-sequencing, spatial transcriptomics trace ‘aggressive behavior’ in SCC
Single-cell RNA-sequencing and spatial transcriptomics may be able to identify tumor-specific keratinocyte subpopulations that mark aggressive squamous cell carcinoma in at-risk patients, according to a review.
Log in or Sign up for Free to view tailored content for your specialty!
Chronic immune-related adverse events common after anti-PD-1 therapy for melanoma
Chronic immune-associated adverse events appeared common after treatment with adjuvant anti-PD-1 therapy among patients with melanoma, according to study results published in JAMA Network Open.
Weight-based dosing strategy could sharply reduce spending on U.S. cancer drugs
Combining weight-based dosing and single-use vial sharing within individual Veterans Affairs hospitals could reduce immune checkpoint inhibitor spending by millions annually, according to study results published in Health Affairs.
Immunotherapy combination improves PFS in pretreated melanoma
The combination of ipilimumab and nivolumab extended PFS compared with ipilimumab alone as second-line therapy for patients with advanced melanoma resistant to PD-1 inhibitors, according to study results published in Nature Medicine.
Survival in Merkel cell carcinoma may improve with Mohs vs. wide local excision
Patients with Merkel cell carcinoma may have better survival outcomes when treated with Mohs micrographic surgery compared with wide local excision, according to a study.
High cardiorespiratory fitness may lower risk for certain cancers up to 40%
High cardiorespiratory fitness was linked to reductions in head and neck, colon, esophagus, stomach, pancreas, liver, rectum, kidney and lung cancers among men, according to a study published in the British Journal of Sports Medicine.
Novel nonsurgical immunotherapy treatment shows promise in basal cell carcinoma
Verrica Pharmaceuticals Inc. has reported lesion clearance data from part one of an ongoing phase 2 study of VP-315 for the treatment of basal cell carcinoma, according to a press release from Verrica’s licensing partner, Lytix Biopharma.
Neoadjuvant T-VEC confers durable survival benefits for resectable melanoma
Neoadjuvant talimogene laherparepvec conferred durable benefits for patients with advanced resectable melanoma, according to study results published in JAMA Oncology.
Black, Hispanic individuals experience poorer outcomes after second cancer diagnosis
An analysis of individuals diagnosed with second primary cancers showed Black individuals exhibited considerably higher risks for cancer-related and cardiovascular-related deaths than white individuals.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read